Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 063355/0913 | |
| Pages: | 18 |
| | Recorded: | 04/18/2023 | | |
| Attorney Dkt #: | DNL-015-02-WO-US2 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18299458
|
Filing Dt:
|
04/12/2023
|
|
Publication #:
|
|
Pub Dt:
|
12/21/2023
| | | | |
|
Title:
|
FUSION PROTEINS COMPRISING PROGRANULIN
|
|
|
Assignee
|
|
|
|
|
| 161 OYSTER POINT BLVD. |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
Correspondence name and address
|
| |
DENALI THERAPEUTICS INC.
|
| |
161 OYSTER POINT BLVD.
|
| |
SOUTH SAN FRANCISCO, CA 94080
|
Search Results as of:
05/25/2024 07:05 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
